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Background: O-antigen (O-polysaccharide) of the lipopolysaccharide is a highly variable cell component of the
outer membrane in Shigella flexneri. It defines the serospecificity and plays an important role in the pathogenesis
of shigellosis. There are two distinct O-antigen forms for the 19 serotypes of S. flexneri: one for serotypes 1–5, X, Y,
7 (and their subtypes), and the other for serotype 6. Although having different basal O-polysaccharide structures,
the two forms share a common disaccharide fragment [→2)-α-L-RhapIII-(1→ 2)-α-L-RhapII]. In serotype 6 and
some non-6 serotypes, RhaIII is O-acetylated at position either 3 or 4 (3/4-O-acetylation), conferring to the hosts a
novel antigenic determinant named O-factor 9. An acyltransferase gene (oacB) responsible for this modification
has been identified in serotypes 1a, 1b, 2a, 5a, and Y, but not in serotype 6.
Results: Using genetic, serological, and chemical approaches, another acyltransferase gene named oacC was
demonstrated to be responsible for the 3/4-O-acetylation on RhaIII in the O-antigen of S. flexneri serotype 6.
Inactivation of the oacC gene resulted in the loss of the 3/4-O-acetyltion, and the cloned oacC gene restored this
modification upon transformation. In accordance with the similarity in the acceptor substrate structure and high
sequence homology (72% identity) between oacC and oacB, oacC has the interchangeable function with the
oacB gene in mediation of the 3/4-O-acetylation. The oacC gene is located in a prophage on the chromosome
and presented in all 77 serotype 6 strains tested.
Conclusions: Identification and functional characterization of the O-acetyltransferase encoding gene, oacC, shows
that it is involved in O-antigen modification by 3/4-O-acetylation on RhaIII specific to serotype 6.
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Shigella flexneri is the major pathogen causing bacillary
dysentery (shigellosis) in developing countries. It is esti-
mated that there are 125 million shigellosis cases annually
in Asia, resulting in 14,000 deaths, the majority of which
are children under 5 years old [1]. The O-polysaccharide* Correspondence: sunqiangzheng@icdc.cn
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unless otherwise stated.chain of the lipopolysaccharide (LPS) called O-antigen is
an important and highly variable cell component presented
on the outer leaflet of the outer membrane. It provides
the basis for serotyping of S. flexneri, and plays an im-
portant role in the pathogenesis of shigellosis [2,3]. The
immune response against the O-antigen can induce
protection that makes it a promising candidate as a
component of shigellosis vaccines [4-7].
Based on the composition and structures of the O-
antigens, S. flexneri can be divided into two main groups:
one for serotypes 1–5, X, Y, and 7, and the other for sero-
type 6. Members of the former group share a linear O-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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repeats (O-units) of one N-acetylglucosamine (GlcNAc)
and three L-rhamnose residues (RhaI-RhaIII): →2)-α-L-
RhapIII-(1→ 2)-α-L-RhapII-(1→ 3)-α-L-RhapI-(1→ 3)-β-
D-GlcpNAc-(1→ [8,9]. Adding various chemical groups
(glucosyl, acetyl or/and phosphoethanolamine) to different
sugars of the tetrasaccharide backbone gives rise to diverse
O-antigen structures and, correspondingly, to various
serotypes [10,11]. Serotype 6 has a different linear O-
polysaccharide backbone with a tetrasaccharide repeat
containing one residue each of N-acetylgalactosamine
(GalNAc) and galacturonic acid (GalA) and two rham-
nose residues (RhaII-RhaIII): →2)-α-L-RhapIII-(1→ 2)-
α-L-RhapII-(1→ 4)-β-D-GalpA-(1→ 3)-β-D-GalpNAc-(1→
[12]. The→ 2)-α-L-RhapIII-(1→ 2)-α-L-RhapII disac-
charide fragment is common for the O-polysaccharides of
both groups of S. flexneri. The observed O-antigen distinc-
tion reflects the genetic diversity of S. flexneri and different
evolutionary origins of serotype 6 compared to other sero-
types, which belong to different lineages of Shigella clones
of Escherichia coli [13,14].
Similar to other Shigella species, the O-antigen gene
cluster involved in the biosynthesis of the S. flexneri O-
polysaccharide backbone is located between the house-
keeping genes galF and gnd on the chromosome [15]. It
contains three main classes of genes: (i) genes of nucleo-
tide sugar biosynthesis pathways; (ii) glycosyltransferase
genes; and (iii) O-unit processing genes including those
for O-antigen flippase (wzx) and O-antigen polymerase
(wzy). Serotypes 1–5, X, Y, and 7 have similar O-antigen
gene clusters whereas in serotype 6 the gene cluster is
different, resulting in the two dissimilar O-antigen back-
bone structures of S. flexneri [15]. The factors responsible
for modification of the backbone including O-antigen
glucosylation (gtr cluster), O-acetylation (oac and oacB),
and phosphorylation (opt) are carried by prophages,
transposon-like structures, or plasmids outside of the O-
antigen gene cluster [10,11,16,17].
Modification of the O antigen by O-acetylation has
been also found in the serotype 6. It was first reported at
position 3 of RhaIII [12], and later found that RhaIII is
partially 3-O-acetylated (major type) and partially 4-O-
acetylated (minor type) [18]. The degree of 3/4-O-acetyl-
ation varies between strains and is thought to contribute
to the serospecificity, which gives rise to a serological
distinction between strains with lower (~30% and 15%)
and higher (~60% and 30%) degrees of O-acetylation at
position 3 and 4 (serotypes 6 and 6a, respectively) [18].
A similar 3/4-O-acetylation on RhaIII also occurs in sero-
types 1a, 1b, 2a, 5a, and Y of S. flexneri [16,18,19], and the
O-acyltransferase-encoding gene, named oacB, has re-
cently been found to be responsible for this modification
in these serotypes [16]. oacB is carried by a transposon-
like structure located upstream of the adrA gene on thechromosome [16]. Further studies have indicated that the
3/4-O-acetylation on RhaIII is widespread in serotypes 1a,
1b, 2a, 5a, 6, and Y and confers to the bacterium a novel
antigenic determinant provisionally named group O-factor
9 [20]. However, the oacB gene cannot be detected from
serotype 6 strains carrying 3/4-O-acetylation [16], indicat-
ing that another unknown gene is involved in the O-
antigen modification in this serotype.
Considering that the O-antigen plays a key role in the
serospecificity and virulence of Shigella, elucidation of
O-antigen modification mechanisms is important for un-
derstanding the O-antigen biosynthesis, antigenicity, and
pathogenicity of S. flexneri, as well as for shigellosis
vaccine development. In this study, we identified the
acyltransferase gene, named oacC, which mediates the
3/4-O-acetylation on RhaIII in serotype 6. The oacC gene
is located in a phage-like structure on the chromosome
and has an interchangeable function with the oacB gene
of serotypes 1a, 1b, 2a, 5a, and Y. However, PCR screen-
ing indicated that gene oacC is specific to serotype 6,
whereas oacB is specific to the other serotypes of S.
flexneri.
Results and Discussion
Identification of an O-acyltransferase gene, oacC, on the
chromosome of S. flexneri serotype 6
Although the O-antigen of S. flexneri serotype 6 carries
3/4-O-acetylation on RhaIII [12,16,18], the oacB gene re-
sponsible for the same modification in serotypes 1a, 1b,
2a, 5a, and Y could not be detected from serotype 6
strains [16]. To identify potential factors associated with
3/4-O-acetylation of serotype 6, we used the OacB protein
sequence of serotype 2a strain Sf301 (Accession No.
NP_706267.1) to search against the GenBank protein data-
base. A predicted acyltransferase protein encoded by gene
SGF_00264 of S. flexneri strains CDC 796–83 and
SFCCH060_3012 of CCH060 was found to show the high-
est homology (72% identity) to OacB (Figure 1). BLAST
search revealed that these strains both carry within their
genomes the serotype 6 O-antigen-specific gene wzx [21],
indicating that they belong to serotype 6. Data presented
below suggest that this OacB homolog is responsible for
the 3/4-O-acetylation on RhaIII in serotype 6; hence it was
named OacC and the encoding gene oacC, following the
designations for OacB and oacB [16].
OacC possesses conserved domains of the acyltransfer-
ase family (COG1835 or acyl_trans_3). It showed 28-39%
identity to predicted acyltransferases of Pseudomonas sp.,
Dechloromonas aromatica, Flavobacterium columnare,
and some other species. OacC was also compared to Oac
(which we have suggested to rename OacA [16]), an O-
acetyltransferase responsible for 2-O-acetylation on RhaI
giving rise to group 6 antigenic determinant in S. flexneri
serotypes 1b, 3a, 3b, 4b, and 7b [8,9]. The two proteins
Figure 1 Sequence alignment of OacB, OacC, and Oac (or OacA), the proteins involved in O-acetylation modification of S. flexneri.
Asterisks and dots indicate the amino acid residues that are identical or similar, respectively. Amino acids identical between OacB and OacC are
shown in shadow. The three major regions conserved among the inner membrane trans-acylase family proteins are marked by black box. The
three critical residues for the Oac (OacA) function are marked by red box.
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among the inner membrane trans-acylase family proteins
(amino acid residues 40 to 57, 69 to 81, and 138 to 156 of
Oac) [22] (Figure 1). In particular, the residues R73 and
R76, which are known to be critical for Oac functioning
[23], are conserved in the three known acyltransferases
(Figure 1).
To reveal a correlation between the presence of oacC
and 3/4-O-acetylation in serotype 6, we performed PCR
screening using the oacC-1 primer pair of serotype 6
strains G1671, G1038, and 51579 (Table 1), all of which
are known to carry 3/4-O-acetylation on RhaIII. The ex-
pected PCR products (350-bp) were amplified from all
three strains, and the PCR product sequences were fully
identical to that of the SGF_00264 gene of CDC 796–83.PCR screening of another 74 serotype 6 isolates collected
in our laboratory showed that all isolates were PCR positive
(Table 2). The 74 strains were also positive for O-factor 9
(Table 2) and therefore should carry 3/4-O-acetylation on
RhaIII. These results, combined with the functional analysis
data described below, suggest that OacC is responsible for
the 3/4-O-acetylation on RhaIII in serotype 6.
Deletion and complementation analysis identifies the
3/4-O-acetylation function of oacC in serotype 6
To confirm the function of the oacC gene, we performed
oacC deletion and complementation assay on serotype 6
strain 51579 using the one-step inactivation of chromo-
somal genes method [26]. The kan-oacC primer pair
(Table 3) carrying sequences complementary to oacC was
Table 1 Strains and plasmids used in this study
Strain or plasmid Characteristic Reference
or source
S. flexneri
51579 Serotype 6, carrying 3/4-O-
acetylation on RhaIII, used for
oacC gene cloning and inactivation
analysis, Aps, Kms
[19]
G1671, G1038 Serotype 6, carrying 3/4-O-acetylation
on RhaIII.
[18]
51579ΔoacC Strain 51579 with the oacC gene
replaced by the kanamycin resistance
gene (kan) from pSR551, Kmr, Aps
this study
51579ΔoacC_pSQZ4 51579ΔoacC transformed by plasmid
pSQZ4
this study
51579ΔoacC_pSQZ5 51579ΔoacC transformed by plasmid
pSQZ5
this study
Sf301ΔoacB Strain Sf301 with the oacB gene
inactive, Kmr, Aps
[16]
Sf301ΔoacB_pSQZ4 Sf301ΔoacB transformed by plasmid
pSQZ4
[16]




DH5α E. coli strain used for plasmid
propagation and gene cloning
TaKaRa
Plasmid
pMD20T T-A vector, Apr TaKaRa
pSR551 Kmr, used for kan gene cloning [24]
pKOBEG A thermosensitive replicon that
carries the λ phage redγβα operon
expressed under the control of the
arabinose-inducible pBAD promoter
[25]
pSQZ4 pMD20T carrying the whole sequence
of the oacB gene from strain Sf301, Apr
[16]
pSQZ5 pMD20T carrying the whole sequence
of the oacC gene from strain 51579,
Apr
This study















1a 106 102 102 0
1b 26 26 26 0
1c =7a 3 0 0 0
1d 14 0 0 0
2a 169 160 160 0
2b 61 0 0 0
3a 18 0 0 0
3b 4 0 0 0
4a 4 0 0 0
4av 4 0 0 0
4b 4 0 0 0
5a 14 9 9 0
5b 5 0 0 0
X 50 0 0 0
Xv 126 0 0 0
Y 39 24 24 0
Yv 20 0 0 0
6 77 77 0 77
7b 4 0 0 0
Table 3 Primers used in this study
Primer Primer sequence (5′-3′) Target gene Reference
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ferase encoding gene (Kmr) from plasmid pRS551. The
PCR amplicon (831-bp) transferred into strain 51579 would
recombine with the oacC gene resulting in a part of the
oacC gene sequence (599-bp, 217 to 815 base) being re-
placed by the Kmr gene. The deletion mutant 51579ΔoacC
was selected on chloramphenicol and kanamycin-
containing plate and detected by PCR amplification of the
oacC gene using the oacC-1 and oacC-2 primer pairs
(Table 3). The product of 350-bp which was amplified from
the wild-type strain, was not obtained from the mutant
51579ΔoacC using the oacC-1 primer pair. However, when
the oacC-2 primer pair was used, a PCR product of 1,681-
bp was amplified from 51579ΔoacC, which, as expected,
was longer than that from the wild-type strain 51579
(1,450-bp). The oacC deletion was further confirmed by
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51579ΔoacC mutants.
The serological features of the mutants were deter-
mined by an agglutination assay using Shigella antisera
of Seiken and anti-O-factor 9 serum. The deletion of
oacC did not affect the type VI antigenicity, with the
51579ΔoacC mutant presenting the same antiserum VI
reactivity as the parental 51579 (Table 4). This observa-
tion is consistent with and confirm the results of Hygge
Blakeman et al. [27], who found that E. coli O147 (which
possesses the same structure as that of serotype 6 O-
antigen except that lacking O-acetylation on RhaIII)
present the same monoclonal antibody MASF VI-1 re-
activity. In contrast, compared to the wild type, the mu-
tant lost the reactivity with 3/4-O-acetylated RhaIII-
specific anti-O-factor 9 serum (Table 4). The O-factor 9
antigenicity of the 51579ΔoacC mutant was restored by
complementation with a functional oacC-carrying plas-
mid pSQZ5 (Table 4).
The O-factor 9 antigenicity was further confirmed by an
immunoblotting assay. The LPSs samples were resolved on
15% SDS-PAGE gel and visualized by silver-staining (Fig-
ure 2A). A typical ladder-like banding pattern of an LPS
with an O-antigen composed of various numbers of O-
units was observed for all strains with no obvious differ-
ence between the parental strain and oacC deletion and
complementation mutants. In Western blot, anti-O-factor
9 serum recognized the ladder-like LPS bands of the func-
tional oacC-carrying strains (51579 wild type and
51579ΔoacC_pSQZ5 complementation mutant) but not
the 51579ΔoacC deletion mutant (Figure 2B).
These findings were confirmed by structure analysis
using 1H and 13C NMR spectroscopy of the O-
polysaccharides isolated from the LPSs. In the spectra
of the wild-type 51579 O-polysaccharide, there were sig-
nals for the 3-O-acetyl group (major) and 4-O-acetyl
group (minor) at δH 2.14 and 2.19, δС 21.9 and 21.8, re-
spectively. Due to electron deshielding effects of O-Table 4 Serotyping of wild-type strains, oacC and oacB
deletion mutants, and complementation transformants
by plasmid pSQZ4 or pSQZ5
Strains Reactivity with typing and grouping antisera
I II III IV V VI 3,4 6 7,8 9
51579 - - - - - + - - - +
51579ΔoacC - - - - - + - - - -
51579ΔoacC_ pSQZ4 - - - - - + - - - +
51579ΔoacC_ pSQZ5 - - - - - + - - - +
Sf301 - + - - - - + - - +
Sf301ΔoacB [16] - + - - - - + - - -
Sf301ΔoacB_pSQZ4 [16] - + - - - - + - - +
Sf301ΔoacB_pSQZ5 - + - - - - + - - +acetylation [28], parts of the signals for H-3/C-3 and H-
4/C-4 of RhaIII were shifted downfield to δH/δС 5.04/
74.2 and 4.80/75.7 as compared with their positions in
the non-O-acetylated RhaIII at δH/δС 3.83/71.2 and
3.38/73.6, respectively (compare published data for
serotype 6a strain G1671 [18]). The degrees of O-
acetylation determined by relative intensities of the 1H
NMR signals for various O-acetylated and non-O-
acetylated RhaIII forms were ~50% at position 3 and ~30%
at position 4. The 1H and 13C NMR spectra of the
51579ΔoacC mutant O-polysaccharide lacked any signals
for O-acetyl groups, and the positions of resonances of H-
3/C-3 and H-4/C-4 of RhaIII at δH/δС 3.84/71.2 and 3.36/
73.7, respectively, indicated that they did not undergo any
deshielding. The spectra of the 51579ΔoacC_pSQZ5 trans-
formant were essentially identical to those of the wild type.
Therefore, the 51579ΔoacC mutant lost the 3/4-O-acetyl-
ation on RhaIII, and this modification was restored by com-
plementation of the mutant with a functional oacC gene
(Figure 3).
It has been proposed that the degree of 3/4-O-acetyl-
ation on RhaIII contributes to the serospecificity of sero-
type 6, which can be divided into subtypes 6 and 6a with
low and high degree of 3/4-O-acetylation, respectively
[18]. We amplified and sequenced the oacC gene in sero-
type 6a strain G1671 and serotype 6 strain G1038 [18],
and found no nucleotide difference between them. Hence,
the variation in the degree of 3/4-O-acetylation is not due
to sequence variation of the oacC gene, and most likely, re-
sults from different storage and/or cultivation conditions.
oacC of serotype 6 has the interchangeable 3/4-O-
acetylation function with oacB of serotypes 1a, 1b, 2a, 5a,
and Y
To determine the distribution of oacC in S. flexneri, PCR
screening of 671 strains of various non-6 serotypes
(Table 2) was performed using the oacC-1 primer pair. No
positive amplification was observed in any of the strains
tested, including all 321 O-factor 9 positive strains of sero-
types 1a, 1b, 2a, 5a, and Y, which do carry 3/4-O-acetyl-
ation (Table 2). We also PCR screened 12 strains of S.
dysenteriae (one each of serotypes 1 to 12), 18 strains of S.
boydii (one each of serotypes 1 to 18), 31 strains of S.
sonnei and 10 strains of E. coli (one each of serogroups
O6, O8, O13, O44, O71, O78, O127, O128, O157, O159)
(Additional file 1: Table S1), and found that all were oacC
negative. These data, combined with results of our previ-
ous studies on the oacB distribution [20], indicate that
oacC is specific to serotype 6, whereas oacB to the other
serotypes of S. flexneri.
To elucidate whether the OacC protein has the inter-
changeable 3/4-O-acetylation function with OacB, we
transferred the oacC-carrying plasmid pSQZ5 into



















































Figure 2 SDS-PAGE and Western blot of LPS from wild-type
strains 51579 (serotype 6) and Sf301 (serotype 2a), their oacC
and oacB deletion mutants, and complementation
transformants by plasmids pSQZ4 and pSQZ5. A. Sliver-staining
detection of LPS profiles on 15% polyacrylamide gels. B. The LPS
separated by SDS-PAGE were transferred onto a PVDF membrane
and hybridized with anti-O-factor 9 serum. An anti-rabbit antibody
labeled with fluorescent IRDye™ 800 (Rockland) was used as the
secondary antibody. Fluorescence was detected using Odyssey
Infrared Imaging System (LI-COR).
Knirel et al. BMC Microbiology 2014, 14:266 Page 6 of 10
http://www.biomedcentral.com/1471-2180/14/266inactivated) [16], and the oacB-carrying plasmid pSQZ4
[16] into 51579ΔoacC, to construct complementation
transformants Sf301ΔoacB_ pSQZ5 and 51579ΔoacC_
pSQZ4, respectively (Table 1). The serological features of
the transformants were determined by an agglutination
assay using Shigella antisera of Seiken (Danka Seiken,
Japan) and anti-O-factor 9 serum, and compared to those
of the Sf301ΔoacB_ pSQZ4 [16] and 51579ΔoacC_ pSQZ5
transformants (see above). It was found that bothSf301ΔoacB_ pSQZ5 and 51579ΔoacC_ pSQZ4 acquired
the agglutination reactivity with anti-O-factor 9 serum,
and the serological features of the oacC transformants
Sf301ΔoacB_ pSQZ5 and 51579ΔoacC_ pSQZ5 were same
as those of the oacB transformants Sf301ΔoacB_ pSQZ4
and 51579ΔoacC_ pSQZ4, respectively (Table 4). In the
immunoblotting assay, anti-O-factor 9 serum recognized
the ladder-like LPS bands of Sf301ΔoacB_ pSQZ4,
Sf301ΔoacB_ pSQZ5, 51579ΔoacC_ pSQZ4, and
51579ΔoacC_ pSQZ5 with no obvious difference found
between the oacB and oacC transformants in each host
(Figure 2B).
The ability of oacB and oacC to transform the deletion
mutants of the heterologous serotypes was further con-
firmed by 1H and 13C NMR spectroscopy, which showed
that the O-polysaccharides of the transformants had ac-
quired the 3/4-O-acetylation on RhaIII (Figure 3). The 1H
and 13C NMR spectra of the O-polysaccharides of
51579ΔoacC_ pSQZ5 (characterized above in mutation
and complementation analysis) and 51579ΔoacC_
pSQZ4 were essentially identical, and, hence, the O-
polysaccharides had the same structure, including the
same total degree of 3/4-O-acetylation (~80% in both).
Serotype 2a strain Sf301, its Sf301ΔoacB deletion mu-
tant, and the Sf301ΔoacB_ pSQZ4 transformant has
been characterized by us earlier, and the 1H and 13C NMR
chemical shifts of their O-polysaccharides have been re-
ported [16]. The 1H and 13C NMR spectra of the O-
polysaccharide of Sf301ΔoacB_ pSQZ5 were similar to
those of Sf301ΔoacB_ pSQZ4, differing only in lower in-
tensities in the former strain of the signals for the 3-O-
acetyl and 4-O-acetyl groups at δH 2.20 and 2.14, δС 22.0
and 22.1, as well as for the O-acetylated forms of RhaIII:
H-3/C-3 at δH/δС 5.09/74.1 and H-4/C-4 at δH/δС 4.80/
75.8. A lower degree of O-acetylation in the Sf301ΔoacB
mutant complemented with the heterologous oacC gene as
compared with the homologous oacB gene (totally ~55%
versus ~90% [16]) could be due to a poorer adaptation of
OacC of serotype 6 for 3/4-O-acetylation of the serotype
2a O-polysaccharide having a different backbone structure.
Gene oacC is carried by a bacteriophage structure on the
chromosome
The DNA regions flanking the oacC gene of partially se-
quenced serotype 6 strains CDC 796–83 and CCH060
were analyzed, and the genomic structures are shown in
Figure 4. In strain CDC 796–83, the oacC gene was
located at the 5′ end of contig NZ_AERO01000013 and
immediately followed by 19 orfs encoding proteins of
phage origin, with 15 of tail structure and assembly
(SGF_00265- SGF_00279), two corresponding to head-
tail adaptor/connector (SGF_00281, SGF_00282), one
putative phage protein (SGF_00283), and one related to
head assembly (SGF_00284) (Figure 4, Additional file 2:
Figure 3 O-Polysaccharide structures of wild-type strains 51579 (serotype 6) and Sf301 (serotype 2a), their oacC and oacB deletion
mutants, and complementation transformants by plasmids pSQZ4 and pSQZ5 [16].
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(>95% identity at protein level), and organized in a similar
manner as, the structure region (SfII_6-SfII_23) of S. flex-
neri bacteriophage SfII genome (NC_021857.1) (Figure 4),
indicating their close evolutionary relationship. In contrast,
it showed no similarity to the oac-carrying bacteriophage
Sf6 and the oac1b-carrying phage-like structure, which are
both responsible for the 2-O-acetylation on RhaI in sero-
types 1b, 3a, 3b, 4b, and 7b [17,29], or to the transposon-
like structure carrying oacB for 3/4-O-acetylation of RhaIII
in serotypes 1a, 1b, 2a, 5a, and Y [16].
To elucidate whether the oacC-carrying prophage
structure occurs in all serotype 6 strains, we performed
PCR screening on 77 serotype 6 strains using the oacC-3
primer pair (Table 3), which covers the oacC gene andFigure 4 Genetic structures of the genomic regions franking oacC ge
(strain CDC796-83), NZ_AKMW01000058 (CCH060), and SfII (NC_021857.1) wer
sequences in NCBI, and shown as thick arrows. The conserved genes of NZ_AE
phage original genes, blue; IS629 and IS630, green; oacC, yellow; pseudo, gray;
CDC796-83 and serotype-converting bacteriophage SfII are marked by red sha
PCR screening are indicated by thin arrows. The locus_tag numbers are showeneighboring SGF_00268 genes. Except for 12 strains, the
expected product (3,850-bp) could be amplified from all
strains tested, and the PCR product sequences were identi-
cal to that of contig NZ_AERO01000013. The oacC gene
of strain CCH060 was found to be located near the end of
contig NZ_AKMW01000058 downstream of two insertion
sequences (IS629 and IS630). They followed a region of
genes encoding putative adhesin and attaching/effacing
protein (SFCCH060_3018- SFCCH060_3019) (Figure 4),
a fragment of unknown function that was also present
in the genomes of several E. coli strains (ES11, LY180,
W, and KO11). The same insertion sequence IS630 also
occurred immediately upstream of oacC in strain CDC
796–83 (Figure 4). Furthermore, PCR amplification and
sequencing performed on the 77 serotype 6 strains usingne in serotype 6 strains. Sequences of contig NZ_AERO01000013
e obtained from NCBI database. The orfs were annotated as submitted
RO01000013 and NZ_AKMW01000058 were shown in different colors:
others, black. Genes sharing >95% identity at amino acid level between
dow. Functional domains of SfII are indicated below. Key primers used for
d in the arrows, and the encoded proteins are indicated above.
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(oacC) and SFCCH060_3017, showed that all but 4 strains
(HN157, HN12, G1038 and 51579) tested were PCR posi-
tive. The four outliers also were negative when further
PCR amplification was performed targeting on genes up to
SFCCH060_3019, probably owing to DNA fragment inser-
tion or deletion events happened in this region. PCR
screening using the oacC-3 primer pair indicated that the
four strains carried the phage-like structure downstream
of oacC, and, therefore, might acquire the 3/4-O-acetyl-
ation by the same phage mechanism.
Conclusions
In this work, the oacC gene encoding a novel acyltrans-
ferase OacC was demonstrated to be responsible for the
3/4-O-acetylation on RhaIII in S. flexneri serotype 6. This
conclusion was supported by the following evidences:
i) the OacC protein encoded by the oacC gene showed
significant similarity to OacB and other acyltransferase
family proteins; ii) deletion of the functional oacC gene
resulted in the loss of the 3/4-O-acetylation in serotype
6; iii) the cloned oacC gene mediated the 3/4-O-acetyl-
ation of RhaIII upon transformation. The oacC gene is
specific to serotype 6 and presented in all strains of this
serotype tested; hence, this gene can be used as a target
for molecular identification of S. flexneri serotype 6.
Although oacC occurs only in serotype 6 strains, it has
the interchangeable function with oacB, which is respon-
sible for 3/4-O-acetylation of RhaIII in non-6 S. flexneri
serotypes, and conversely oacB can confer this modifica-
tion to serotype 6. This could be expected as oacC and
oacB possess a high homology (72% identity), and the
O-polysaccharides of serotype 6 and the other S. flexneri
serotypes share the→ 2)-α-L-RhapIII-(1→ 2)-α-L-RhapII
disaccharide fragment.
As opposite to the oacB gene localized in a transposon-
like structure, the oacC gene is carried by a chromosomal
phage-like structure adjacent to the adhesin region that is
conserved in serotype 6. Therefore, the mechanisms of 3/
4-O-acetylation in serotype 6 and the other serotypes (1, 2,
5 and Y) are distinct, which is not surprising as they have
different evolutionary origins and belong to different line-
ages of Shigella clones of E. coli [13,14]. Accordingly, the
divergent Oacs might have been gained from different spe-
cies in independent events. These findings enhance our
understanding of the genetic basis of O-antigen modifica-
tions in S. flexneri.
Methods
Bacterial strains, plasmids, and culturing conditions
Strains and plasmids used in this study are listed in
Table 1. S. flexneri serotype 6 strain 51579 [16] carrying
3/4-O-acetylation on RhaIII in the O-antigen was used as
the reference strain for oacC gene cloning and deletionanalysis. The oacC gene deletion mutant 51579ΔoacC
and oacB gene deletion mutant Sf301ΔoacB [16] were
employed as hosts for the plasmid pSQZ4 and pSQZ5
transformation analysis. Seventy-seven S. flexneri sero-
type 6 strains, 671 strains of other serotypes of S. flex-
neri (Table 2), 12 strains of S. dysenteriae (one each of
serotypes 1 to 12), 18 strains of S. boydii (one each of se-
rotypes 1 to 18), 31 strains of S. sonnei and 10 strains of
E. coli (one each of serogroups O6, O8, O13, O42, O71,
O78, O127, O128, O157, O159) were used for oacC gene
PCR detection analysis (Additional file 1: Table S1). S.
flexneri strains were either isolates from patients in a
surveillance program performed by China CDC during
2000 to 2012 or were purchased from the National Col-
lection of Type Cultures (NCTC) or were kindly donated
by B. Liu (Nankai University, Tianjin). E. coli DH5α was
used for plasmid propagation. pMD20T vector (TaKaRa,
Japan) was used for DNA sequencing and oacC gene
function analysis. Plasmid pRS551 was used for kanamy-
cin resistance gene amplification. pKOBEG encoding a
homologous recombination system was used in oacC
gene deletion analysis. Strains were grown in a 37°C in-
cubator or orbital shaker in Luria-Bertani (LB) medium
supplemented with ampicillin (100 μg ml−1), kanamycin
(40 μg ml−1), or chloramphenicol (50 μg ml−1) when
appropriate.
Bioinformatics analysis
The protein sequence of O-acyltransferase for 3/4-O-
acetylation (OacB) (accession No. NP_706267.1) of S. flex-
neri strain Sf301 (serotype 2a) was searched against the
GenBank protein database, using the BLASTP web server
(http://www.ncbi.nlm.nih.gov/BLAST). Homologs of OacB
were aligned using the ClustalW2 program in the EMBL-
EBI (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
DNA techniques
Primer pairs used in this study are listed in Table 3. The
oacC-1 primer pair was used for oacC gene detection.
The oacC-2 primer pair was used for oacC gene function
analysis. The oacC-3 and oacC-4 primer pairs were used
to amplify regions up and downstream of oacC in sero-
type 6 isolates. Oligonucleotide primers were synthesized
by Sangon Biotech (Shanghai). PCR amplifications were
performed using a TaKaRa PCR Amplification Kit (Takara,
Japan) following a standard protocol. PCR products ampli-
fied from strain 51579 using the oacC-2 primer pair were
purified and cloned into the T-vector pMD20T (TaKaRa,
Japan), which carries an additional T at both 3′ terminus
and can complement the A base of the PCR product, to
generate the pSQZ5 expression plasmid. The recombinant
plasmids were first transformed into commercial E. coli
DH5α competent cells (TaKaRa, Japan), and then into S.
flexneri strains tested, using a standard protocol [30]. The
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with ampicillin (100 μg ml−1) and further confirmed by
PCR amplification of the oacC gene.
oacC gene functional deletion and complementation
analysis
Deletion of the oacC gene was performed on S. flexneri
serotype 6 strain 51579 using a one-step method as de-
scribed previously [26]. The kanamycin resistance gene
(Kmr) was PCR amplified from plasmid pRS551 using
the kan-oacC primer pair (Table 3). The PCR products
were electroporated into strain 51579 carrying plasmid
pKOBEG (encoding a homologous recombination sys-
tem for oacC gene inactivation) and selected on an LB
plate with chloramphenicol (50 μg ml−1) and kanamycin
(40 μg ml−1). oacC gene deletion mutant 51579ΔoacC
was confirmed by a slide agglutination assay using anti-
O-factor 9 serum [20] and PCR amplification of oacC
using the oacC-1 and oacC-2 primer pairs. Plasmid pSQZ5
and pSQZ4 [16] were transferred into 51579ΔoacC and
Sf301ΔoacB [16], giving rise to complemented strains
51579ΔoacC_ pSQZ5, 51579ΔoacC_ pSQZ4 and
Sf301ΔoacB_pSQZ5, respectively.
Serotyping analysis
The serological features of S. flexneri strains were deter-
mined by a slide agglutination test using commercially
available Shigella monovalent antisera kit (Denka Seiken,
Japan) and 3/4-O-acetylated RhaIII-specific anti-O-factor
9 serum prepared previously [20].
Western blot assay
LPSs were prepared using an LPS extraction Kit (iNtRON,
South Korea) according to the manufacturer’s instructions.
The LPSs were electrophoresed on 15% polyacrylamide
gels and detected by silver staining as described [31]. A
Western blot assay of the LPSs was performed as de-
scribed [20]. Briefly, the LPSs separated by SDS-PAGE
were transferred onto a polyvinylidene difluoride (PVDF)
and incubated with anti-O-factor 9 serum. After washing,
the membrane was incubated with anti-rabbit antibody la-
beled with fluorescent IRDye 800 (Rockland). The fluores-
cence was detected using an Odyssey infrared imaging
system (LI-COR).
O-polysaccharide isolation and structure analysis
For O-polysaccharide structure analysis, the LPSs of
wild-type strains, deletion mutants and transformants
were isolated by phenol-water extraction of bacterial
cells [32]. The crude extract without separation of layers
was dialyzed against tap water, nucleic acids and proteins
were precipitated by adding aqueous 50% CCl3CO2H at
4°C to reach pH 2, the supernatant was dialyzed against
distilled water and freeze-dried. The purified LPSsobtained in yields of 5% to 7% were hydrolyzed with aque-
ous 2% acetic acid at 100°C until formation of a lipid pre-
cipitate (1–2 h), and the released O-polysaccharides were
isolated in yields of 12% to 34% from the supernatant by
gel permeation chromatography on Sephadex G-50 Super-
fine (Amersham Biosciences, Sweden) in 0.05 M pyridi-
nium acetate buffer (pH 4.5) monitored with a differential
refractometer (Knauer, Germany).
Structures of the O-polysaccharides were elucidated
using two-dimensional nuclear magnetic resonance
(NMR) spectroscopy, including a 1H,13C heteronuclear
single-quantum coherence (HSQC) experiment, es-
sentially as described previously [33]. Positions of
O-acetyl groups were determined by characteristic
low-field displacements of NMR signals for 1H and
13C atoms at the O-acetylation sites. The degree of O-
acetylation was determined by relative integral inten-
sities of the 1H NMR signals for the O- and N-acetyl
groups, 3-O- and 4-O-acetylated and non-O-acetylated
RhaIII.
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